key: cord-0955838-l4imcuao
authors: Nunes, Danilo Rosa; Braconi, Carla Torres; Ludwig-Begall, Louisa F.; Arns, Clarice Weis; Durães-Carvalho, Ricardo
title: Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution
date: 2022-05-24
journal: PLoS One
DOI: 10.1371/journal.pone.0268389
sha: 2ae5e3ff800ebac00ee0dfcb490628222f6e8a7b
doc_id: 955838
cord_uid: l4imcuao

Nearly two decades after the last epidemic caused by a severe acute respiratory syndrome coronavirus (SARS-CoV), newly emerged SARS-CoV-2 quickly spread in 2020 and precipitated an ongoing global public health crisis. Both the continuous accumulation of point mutations, owed to the naturally imposed genomic plasticity of SARS-CoV-2 evolutionary processes, as well as viral spread over time, allow this RNA virus to gain new genetic identities, spawn novel variants and enhance its potential for immune evasion. Here, through an in-depth phylogenetic clustering analysis of upwards of 200,000 whole-genome sequences, we reveal the presence of previously unreported and hitherto unidentified mutations and recombination breakpoints in Variants of Concern (VOC) and Variants of Interest (VOI) from Brazil, India (Beta, Eta and Kappa) and the USA (Beta, Eta and Lambda). Additionally, we identify sites with shared mutations under directional evolution in the SARS-CoV-2 Spike-encoding protein of VOC and VOI, tracing a heretofore-undescribed correlation with viral spread in South America, India and the USA. Our evidence-based analysis provides well-supported evidence of similar pathways of evolution for such mutations in all SARS-CoV-2 variants and sub-lineages. This raises two pivotal points: (i) the co-circulation of variants and sub-lineages in close evolutionary environments, which sheds light onto their trajectories into convergent and directional evolution, and (ii) a linear perspective into the prospective vaccine efficacy against different SARS-CoV-2 strains.

In the last two decades, human health has been threatened by the emergence of three important zoonotic and pathogenic betacoronaviruses, namely the severe acute respiratory syndrome coronavirus (SARS-CoV) [1] , the Middle East respiratory syndrome coronavirus (MERS-CoV) [ (COVID- 19) pandemic, SARS-CoV-2 [3] . Likely originated from bats, pandemic SARS-CoV-2, like other endemic human alpha-(NL63 and 229E) and beta-(OC43 and HKU1) CoVs known for causing upper respiratory tract infections, overcame the interspecies barrier as a result of spillover and/or recombination events, and gained a pervasive ability to rapidly infect and spread around the globe [4] [5] [6] .

The COVID-19 pandemic precipitated an intense genomic surveillance via data depositories and sequencing platforms and led to an unprecedented accumulation of public genomic data concerning a human pathogenic virus [5, 7] . The sheer amount of available sequencing data has the potential to facilitate higher-precision micro-evolutionary analyses mapping escape and point mutations in presumed positively selected sites and residues putatively associated to an increased virus fitness and pathogenesis and allows inferences concerning the dynamics of SARS-CoV-2 spread [8, 9] .

Although the analysis of micro-evolutionary mechanisms is of paramount importance and may provide powerful information to promote the prediction of vaccination perspectives and the tracing of SARS-CoV-2 epidemiological chains, there is as yet a lack of data-based investigations examining the presence of eventual shared mutations and their evolutionary characteristics in classified SARS-CoV-2 Variants of Concern (VOC) and Variants of Interest (VOI) [10, 11] .

Given the importance of monitoring mutations to track the emergence of novel variants, here we investigate the influence of directional selection and the dynamics of SARS-CoV-2 genomic plasticity in VOC and VOI by clustering partition high-scale phylogenetic and directional evolution (DEPS) approaches. Additionally, we show the presence of several mutations common for both VOI/VOC and convergently emerged sub-lineages, and provide a perspective of possible effects on the vaccination efficacy and the ongoing COVID-19 pandemic.

High-coverage and complete HCoV-229E and HCoV-NL63 (alpha-CoVs), HCoV-OC43, HCoV-HKU1, MERS-CoV, SARS-CoV and SARS-CoV-2 VOC and VOI (beta-CoVs) genome sequences (� 29,000 bp), sampled from humans, were retrieved from the Global Initiative on Sharing Avian Influenza Data-EpiCoV (GISAID-EpiCoV) and GenBank databases at three different times, each date representing a snapshot of the COVID-19 spread at that time: February 12 th (MERS-CoV, SARS-CoV and SARS-CoV-2), July 12 th (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1 and SARS-CoV-2) and updated in August 26 th 2021 (SARS-CoV-2), totalling 238,990 sequences. With regards to SARS-CoV-2, we particularly focused on strains of countries from South America, China, India, and the United States of America (USA). At the time of analysis, India, the USA, and Brazil had reported the largest numbers of cumulative confirmed COVID-19 cases and deaths. This approach was used to compare putative mutual sites and residue changes under directional evolution over time [12] .

Subsequently, sequences were filtered via Sequence Cleaner, a biopython-based program, utilising the following script: sequence_cleaner -q INPUT_DIRECTORY -o OUTPUT_DIR-ECTORY -ml 29,000 (MINIMUM_LENGTH) -mn 0 (PERCENTAGE_N)-remove_ambiguous. The outcome was a set of unambiguous sequences equal to and greater than 29,000 pb with zero percent of unknown nucleotides. Next, the datasets were aligned by adding codingsequences related to references for HCoV-229E (NC_002645.1), HCoV-NL63 (NC_005831.2), HCoV-OC43 (NC_006213.1), HCoV-HKU1 (NC_006577.2), MERS-CoV (NC_038294.1), SARS-CoV (NC_004718.3), and SARS-CoV-2 (NC_045512.2), using default settings, with the rapid calculation of full-length multiple sequence alignment of closely-related viral genomes (MAFFT v.7 web-version program; https://mafft.cbrc.jp/alignment/software/ closelyrelatedviralgenomes.html) and were edited by the UGENE v.38.1 [13] .

A methodological approach to extract large-scale phylogenetic partitions was applied to identify transmission cluster chains on the large Maximum Likelihood (ML) phylogenetic trees of the SARS-CoV-2 variants circulating in South America, China, India and the USA on the basis of a depth-first search algorithm which unifies evaluation of node reliability, tree topology and patristic distance [14] . In this case, different datasets from each particular SARS-CoV-2 scenario were used in order to extract the clustering and sub-clustering data. Therefore, each ML tree was implemented in FastTree v.2.1.7 by using the standard implementation General Time Reversible (GTR) plus CAT with 20 gamma distribution parameters and a mix of Nearest-Neighbor Interchanges (NNI) and Sub-Tree-Prune-Regraft (SPR) [15] . Thereafter, in view of identifying SARS-CoV-2 cluster transmission events, for datasets comprising more than 100 sequences, we first selected sequences (one per cluster) from nodes/sub-trees with � 2 distinct individuals and � 90% reliability of statistical support (Shimodaira-Hasegawa test), where initially the patristic distance was adjusted to find a representative number of clusters (n = 100, which represent 100 sequences) from each large reconstructed ML tree. In addition to this strategy, a second approach included sub-clustering analysis as an indirect way to infer and investigate the possibility of co-circulating sub-lineages. For this, we selected sequences (two per cluster) with � 95% node reliability of statistical support from a threshold of 0.05, thus corresponding to the 5 th percentile when considering the whole-tree patristic distance distribution.

Before proceeding to directional evolution analysis, sequence datasets from the output provided by the clustering analyses were submitted to the Genetic Algorithm for Recombination Detection (GARD), a likelihood-based tool to pinpoint recombination breakpoints [16] . To check the outcome of the strategy described above, an additional test was conducted using the Pairwise Homoplasy Index (PHI; default settings) [17] . Evidence-based analysis through phylogenetic maximum-likelihood was then performed implementing the Datamonkey webserver and the program Hyphy v.2.5 to track directional selection in amino acid sequences (DEPS) [18] . The DEPS method identifies both the residue and sites evolving toward it with great accuracy and detects frequency-dependent selection-scenarios as well as selective sweeps and convergent evolution that can confound most existing tests [8] . Further, the DEPS method has shown better performance than (traditional) substitution rate-based analyses (dN/dS) in detecting transient and frequency-dependent selection and directionally evolving sites and residues. For the most part, a Beta-Gamma site-to-site rate variation was used to conduct the analysis. The best-fit protein substitution model was chosen according to the corrected Akaike Information Criterion (cAIC). Only target sites and residues with Empirical Bayes Factors for evidence in favour of a directional selection model equal to or greater than 100 were considered for further exploration. Certain datasets, randomly chosen, were run multiple times (more than eight) to confirm obtained results.

publications-data/distribution-confirmed-cases-mers-cov-place-infection-and-month-onset-1), respectively. Information concerning SARS-CoV-2 was collected from the World Health Organization (WHO) (https://covid19.who.int/). Population demographic data were retrieved from the Our World in Data website (https://ourworldindata.org/grapher/world-populationby-world-regions-post 1820?tab = table&country = Oceania~~North +America~Europe~Africa~Asia).

Statistical analyses were performed using one-way analysis of variance (ANOVA) and nonparametric methods followed by post hoc Kruskal-Wallis and Friedman (both with Dunn's Multiple Comparison), and Bartlett's tests (Tukey's, Newman-Keuls and Bonferroni's multiple comparisons). Additionally, Mann Whitney and Wilcoxon matched-pairs signed-rank (T test) and Pearson/Spearman (Correlation), all one-tailed methods with 99% confidence interval (CI), were run. P-values equal to or less than 0.005 (p � 0.005, SARS-CoV-2 from South America: DEPS [sites and/or residues] vs infections) and 0.05 (p � 0.05, SARS-CoV-2 from Brazil, China, India and the USA: DEPS [residues] vs circulating variants and infections) were considered as statistically significant. Data analyses were carried out using GraphPad Prism v. 5 

Recombination is known to be a crucial evolutionary process for many RNA viruses [19] [20] [21] ; the process is frequently observed in the Coronaviridae family where recombination is likely facilitated by discontinuous transcription involving jumps of the replication-transcription complex during minus strand RNA synthesis. However, the consequences of recombination events occurring in the context of the current SARS-CoV-2 VOC/VOI evolutionary landscape are still speculative [22, 23] . Here, we address this knowledge gap, revealing the presence of recombination and shared mutations in the SARS-CoV-2 Spike-encoding protein, demonstrating them to be under directional and convergent evolution amongst SARS-CoV-2 VOC/VOI and sub-lineages, and tracing an interconnection with viral spread. First, endemic and epidemic human coronaviruses (HCoVs) were compared to identify similar evolutionary patterns that could help clarify the evolution of SARS-CoV-2. An initial recombination breakpoint analysis showed that four of six HCoVs analyzed presented such signals ( Fig 1A) . Endemic viruses OC43, NL63 and HKU1 also showed a similar pattern of residue accumulation and directional evolution, despite these viruses being subject to differing selective pressures [24] .

A subsequent comparison of SARS-CoV-2 to the other two pathogenic HCoVs (SARS-CoV and MERS-CoV), highlighted differences in the number of directionally-evolving sites and residues ( Fig 1B) . These patterns, putatively reflecting the initial evolutionary paths of the individual viruses, may suggest that SARS-CoV was initially under lower positive evolutionary pressure than MERS-CoV and SARS-CoV-2. Nevertheless, deletions and mutations acquired by SARS--CoV have been shown to have had an impact on adaptation to human-to-human transmission, modifying both the capacity for viral proliferation and profiles of pathogenesis [25] [26] [27] .

The evolution of SARS-CoV-2 was initially marked by genetic drift in a typical process of neutral evolution [28, 29] ; the virus reached a large number of new and susceptible hosts and, although some mutations appeared along the genome, there was no significant shift [30] . However, as SARS-CoV-2 rapidly spread worldwide [31, 32] , fitness changes resulting from mutations in the viral genome as well as the emergence of new variants were increasingly reported [33] [34] [35] .

The first epidemic wave of SARS-CoV-2 severely affected most countries in South America as a probable result of multiple viral introductions [36] ; rapid increases of case numbers were especially reported in Brazil, the largest and most populous country in Latin America [37, 38] . The uncontrolled viral spread created a favorable scenario for the emergence of new variants [39] [40] [41] [42] . To identify the impact of directional-positive selection sites at the rate of infections under these particular conditions, we traced the evolutionary scenario of SARS-CoV-2 in South America (via analysis of a significant and representative amount of genome sequences).

Remarkably, our data showed that an increase of DEPS was correlated with viral spread dynamics, with Brazil exhibiting a lower proportion of COVID-19 cases (per 100,000 inhabitants) when compared to French Guiana and the same amount of SARS-CoV-2 clusters inferred in Chile (n = 97) (Fig 1C) , probably due to a higher diversity of circulating viruses. Our results also highlighted a series of mutations; while certain mutations have previously been described, but have hitherto remained unidentified in SARS-CoV-2 VOC and VOI, multiple further mutations are identified for the first time in this study, to our knowledge (Table 1) . 

Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants Table 1 Spike mutations such as E484K, N501Y, L452R, S13I and W152C, seem to be fundamentally important in the process of adaptation of SARS-CoV-2 to human hosts, this by enhancing the affinity to the human ACE2 receptor and mediating immune system evasion [43] [44] [45] (Table 1) , allowing for inferences concerning a SARS-CoV-2 reproductive number increase. An increase in virus circulation augments the chance of viral coinfection, which in turn (and as a prerequisite for recombination), can heighten the risk of emergence of new variants [46, 47] .

The Delta variant, first identified in late 2020 in India as B.1.617.2 [48] , harbors a constellation of non-synonymous mutations in the Spike protein [49] and had become the leading VOC worldwide by the end of July 2021, this VOC accounted for 90% of all sequenced samples [50, 51] . Brazil, India and the USA, the countries most severely affected by the pandemic, are now once again threatened by this highly contagious variant. Analysis of the molecular evolution of SARS-CoV-2 taking into account the influence of local demography in these specific scenarios has the potential to generate important insights into the spread and infection dynamics of this pathogen.

Using SARS-CoV-2 sequences from China (the most populated country in the world and also a country where control measures against COVID-19 infections have been deployed very effectively) as reference, we analyzed all datasets from Brazil, India, and the USA via a large-scale phylogenetic partitions analysis. Increases in SARS-CoV-2 infections were observed to be proportional to locally circulating variants and were not (in the scenarios analyzed), correlated with any particular demography ( Fig 1D) ; this indirectly reinforces the importance of measures implemented to avoid viral propagation. Analysis of phylogenetic partition clusters along the length of the circa 30 kb CoV genome evidenced several directionally-evolving sites under convergent evolution. Thus, a possible 

Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants association between the number of infections from locally circulating SARS-CoV-2 variants carrying distinct residue profiles as well as sites in the Spike-encoding protein under DEPS may be established ( Fig 1D) . Interestingly, this supports a hypothesis of convergent evolution due to repeated and multiple site-specific substitutions in distinct SARS-CoV-2 VOC and VOI (see Table 1 and Fig 2) . Additionally, we also inferred the possible appearance of SARS-CoV-2 sub-lineages and traced the influence of an environment favoring directional evolution acting on SARS-CoV-2 variants. We showed different patterns among sites in the VOC and VOI, with a particular emphasis on the Kappa VOI currently circulating in the USA. We further demonstrated recombination among SARS-CoV-2 VOC and VOI from India (Beta, Eta and Kappa) and the USA (Beta, Eta and Lambda) ( Fig 3A) .

As one of the first countries in the world to develop efficient immunizations and implement a vaccination policy, the USA vaccinated more than 30% of its population by April 2021 [52, 53] . By September 2021, 60% of the booster-immunized population possessed neutralizing antibodies against several viral variants [54] . Similar outcomes were observed following widespread vaccination with various SARS-CoV-2 vaccines (different technologies leveraged for vaccine production) in many other regions, including South America and India [55, 56] . We hypothesize that the site-specific mutations found under convergent evolution at strategic positions in the SARS-CoV-2 VOC/VOI Spike protein targeted by vaccine-induced neutralizing antibodies, as shown by Andreata-Santos et al. (2022) [57] , may also help to explain these findings (Fig 4) . Nonetheless, viral circulation in the face of incomplete immunization has been described as one of the probable causes of the Table 1 and Fig 1D Venn 

Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants emergence of new variants [42] (Sabino et al., 2021) . Accordingly, our own analysis identified SARS-CoV-2 VOC and VOI sub-clusters (Fig 3B) , thus indicating co-circulation of variants and sub-lineages carrying new mutations under convergent evolution. Surprisingly, the same evolutionary pattern was also observed for other endemic and epidemic CoVs studied (see Data availability).

This study demonstrates the influence of positive directional evolution on SARS-CoV-2 circulating in South America and in those countries most severely affected by the COVID-19 pandemic. Furthermore, our methodology allowed the identification of distinct transmission sub-clusters and recombination breakpoints in many SARS-CoV-2 variants, to our knowledge, not previously shown so far. We were able to indirectly infer transmission of a viral epidemiological chain and the generation of new variants. Through sequence data collected in February, July and August 2021, we also further identified and classified several convergently emerged shared mutations in different SARS-CoV-2 VOC and VOI. Lastly, we hypothesize that the cocirculation of SARS-CoV-2 variants and their possible sub-lineages takes place within a very close evolutionary environment, which can be translated to a setting of strong convergent and directional evolution. The latter may have affected the number of different lineages within each country, with highly infected countries being impacted the most (as can be seen from comparison against China). This agrees with the general virological perspective that the larger the number of viruses circulating, as well as the number of lineages within a region, the more likely it becomes that sub-lineages will originate and spread. Our results confirm the importance of critical assessment, monitoring, and control of SARS-CoV-2 lineages and sub-lineages throughout the pandemics, even more so in countries with large populations where many opportunities arise for positive selection, due to both recurrent substitutions and recombination events. 

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century

Hosts and Sources of Endemic Human Coronaviruses

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

Coronavirus biology and replication: implications for SARS-CoV-2

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology

A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus

Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy

SARS-CoV-2 Variant Classifications and Definitions

SARS-CoV-2 one year on: evidence for ongoing viral adaptation

Influence of directional positive Darwinian selection-driven evolution on arboviruses Dengue and Zika virulence and pathogenesis

Unipro UGENE: a unified bioinformatics toolkit

A novel methodology for large-scale phylogeny partition

FastTree 2-approximately maximum-likelihood trees for large alignments

GARD: a genetic algorithm for recombination detection

Application of phylogenetic networks in evolutionary studies

HyPhy 2.5-A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies

Genetic Recombination in RNA Viruses

The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing. 2 nd ed

Genetic Recombination, and Pathogenesis of Coronaviruses

A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic

Possible recombination between two variants of concern in a COVID-19 patient

Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host

Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene

SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen

The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape

Full-genome sequences of the first two SARS-CoV-2 viruses from India

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Spike mutation D614G alters SARS-CoV-2 fitness

Evolution and epidemic spread of SARS-CoV-2 in Brazil

Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in

Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus

A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

SARS-CoV-2 variants, spike mutations and immune escape

SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains

What You Need to Know About Variants. 02 February 2022

Genetic emergence of B.1.617.2 in COVID-19

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants

Genomic surveillance tracks the first communitary outbreak of Delta (B.1.617.2) variant in Brazil

Epidemiological Update: Increase of the Delta variant and its potential impact in the Region of the Americas

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence-25

Spikevax and Moderna COVID-19 Vaccine

Durability of mRNA-1273 vaccineinduced antibodies against SARS-CoV-2 variants

Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control realworld study

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

From Alpha to Omicron SARS-CoV-2 variants: What their evolutionary signatures can tell us

VMD-Visual Molecular Dynamics

We gratefully acknowledge the authors and both the originating and submitting laboratories for the sequence data in GISAID EpiCoV and GenBank on which this work is based. The authors also thank the Rede Corona-Ô mica/MCTI/FINEP, the National Laboratory for Scientific Computing (LNCC/MCTI, Brazil) for providing HPC resources of the Santos Dumont supercomputer (ID #45691), and Prof. Luiz Mário Ramos Janini for fruitful discussion.